FOXO3 rs4946935: Longevity and Healthspan Variant
rs4946935 is a well-studied single nucleotide polymorphism located in an intronic region of the FOXO3 gene on chromosome 6. Research has identified it as part of an evolutionary conserved longevity locus linked to reduced cardiovascular morbidity and enriched frequency among long-lived cohorts, such as centenarians. While carrying associated alleles correlates with biological resilience, overall longevity remains a complex polygenic trait shaped heavily by lifestyle and environment.
What each genotype means
Typical longevity-associated profile
This is the major genotype for this variant. Research indicates that individuals with this genotype do not carry the specific allele associated with the enhanced FOXO3 enhancer activity observed in some cohorts. While this is the most frequent genotype, it does not imply a negative health outcome, as longevity is a complex trait influenced by many genetic and environmental factors.
This is the most common genotype found across global populations.
Enhanced FOXO3 activity potential
You carry one copy of the A allele, which research suggests may act as a binding site for transcription factors that can enhance FOXO3 gene expression. Increased FOXO3 expression is theorized to improve cellular stress response and repair mechanisms, which are potentially beneficial for longevity and healthspan. These associations are observed in various populations but can vary by sex and ancestral background.
Carried by a significant portion of the population; the A allele frequency is roughly 0.28–0.35 globally.
High potential for FOXO3 expression
You carry two copies of the A allele, which is associated with increased FOXO3 enhancer activity compared to the G allele. Scientific literature suggests that higher FOXO3 expression levels may help cells better manage oxidative stress and improve DNA repair efficiency, traits often observed in long-lived individuals. While this genotype is enriched in some cohorts of centenarians, it remains one part of a complex genetic architecture influencing healthspan and is not a guarantee of any specific health outcome.
This genotype is less common than the others, occurring in roughly 8–12% of individuals in many populations.
Genomic Location and Variant Profile
The single nucleotide polymorphism rs4946935 represents a common non-coding nucleotide transition within the forkhead box O3 (FOXO3) gene located on chromosome 6q21. Because it resides in an intronic region rather than an exon, it does not alter the primary amino acid sequence of the resulting protein. Instead, variants within this non-coding cluster appear to influence transcription factor binding sites, enhancer function, or alternative splicing mechanisms that modulate the expression of FOXO3 under physiological stress. Functional mapping studies have highlighted rs4946935, alongside neighboring markers such as rs12206094 and rs2802292, as key regulatory candidates within the locus. Due to strong linkage disequilibrium across the broad FOXO3 non-coding region, rs4946935 often travels together in conserved haplotypes that have drawn intense scrutiny in human aging and healthspan genetics.
The Biological Role of FOXO3 in Cellular Defense
The FOXO3 gene encodes a central transcription factor in the evolutionarily conserved insulin/insulin-like growth factor 1 (IGF-1) signaling cascade. It acts as an orchestrator of cellular homeostatic programs, directly turning on genes responsible for DNA repair, antioxidant defense, autophagy, and stem cell preservation. When cells encounter metabolic deprivation or oxidative stress, FOXO3 translocates to the nucleus to trigger cellular maintenance programs that delay senescence and maintain genomic integrity. Dysregulation or reduced activity of FOXO3 has been linked to accelerated vascular aging, metabolic decline, and neurodegenerative processes. Because high levels of sustained FOXO3 activation mitigate stress-induced damage across tissues, genetic variations that enhance its expression or basal regulatory efficiency are hypothesized to extend healthy life expectancy and protect vital cardiovascular tissues from degenerative damage.
Longevity and Cardiovascular Health Associations
Multiple candidate gene and genome-wide replication studies have evaluated rs4946935 in the context of exceptional longevity and age-related pathologies. Meta-analyses and cohort evaluations, including studies published in PNAS and LongevityMap records, have repeatedly demonstrated statistically significant enrichment of specific alleles in long-lived human cohorts, including nonagenarians and centenarians. Beyond extreme survival phenotypes, the FOXO3 haplotype cluster containing rs4946935 has been correlated with reduced rates of stroke, lower cardiovascular mortality, and improved metabolic parameters in aging populations. The statistical strength of this association is characterized as moderate; while FOXO3 is one of the most consistently replicated longevity loci across diverse ancestries alongside APOE, its individual effect size on lifespan remains modest and functions in concert with hundreds of other polygenic loci.
Interpreting Genetic Results in Daily Life
Discovering your genotype at rs4946935 offers an intriguing look into basic cellular aging biology, but it cannot predict an individual's actual lifespan or diagnose medical conditions. A favorable genotype does not make an individual immune to cardiometabolic disease, nor does a neutral profile mean one is destined for early health decline. Modifiable lifestyle factors—including a nutrient-dense diet, consistent physical activity, restorative sleep, smoking cessation, and routine cardiovascular screenings—wield a far stronger impact on long-term vitality than any individual non-coding SNP. Consumers should regard their rs4946935 status purely as educational insight into their inherited biological background rather than a clinical prognosis. Any preventative health interventions, biomarker screenings, or medical decisions should be planned in partnership with a qualified healthcare professional.
How common is this variant?
The minor A allele occurs at a frequency of roughly 0.28 to 0.35 across global populations according to gnomAD, with homozygous AA genotypes present in approximately 8% to 12% of individuals depending on ancestral background.
Frequently asked questions
Does having the longevity-associated allele at rs4946935 guarantee I will live longer?
No, it does not guarantee a longer life. While the A allele is statistically enriched in cohorts of nonagenarians and centenarians, human longevity is heavily influenced by lifestyle, environment, socioeconomic conditions, and hundreds of other genes.
What is the biological function of the FOXO3 gene?
FOXO3 encodes a transcription factor that helps protect cells from oxidative stress, repairs damaged DNA, removes cellular debris via autophagy, and maintains stem cell health. It plays an important role in delaying cellular senescence and vascular aging.
Is rs4946935 used for medical diagnosis?
No, rs4946935 is not a clinical diagnostic marker. It is a research-associated common variant that provides statistical insights into biological aging and healthspan, but it cannot diagnose or rule out any health disorder.
Can lifestyle habits influence FOXO3 activity regardless of my genotype?
Yes. Lifestyle practices such as regular aerobic exercise, caloric moderation, intermittent fasting, and reducing chronic systemic inflammation are known to stimulate FOXO3 signaling pathways independently of your inherited genetic variants.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4946935?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FOXO3
Well-characterized non-headline FOXO3 variant associated with healthy aging, lower cardiovascular mortality, and survival beyond age 90.
Non-coding FOXO3 variant identified in longitudinal aging studies as conferring an advantage for survival from midlife into advanced old age.
Common upstream intronic regulatory variant in FOXO3 correlated with human longevity and enhanced resilience against metabolic disease.
Functional non-coding variant in the key longevity regulator FOXO3 contributing to extended survival and healthspan.
An intronic variant in the FOXO3 gene consistently associated with human longevity and survival to extreme old age across multiple ethnic cohorts.
Intronic variant in FOXO3 significantly associated with exceptional longevity and survival to advanced old age, showing allele-dependent enhancer activity.